In the in vivo models, GNC–siRNA complex enhanced the blood circulation and the accumulation of NGF siRNA to tumour sites (Fig. 5), induced significant NGF silencing (Figs 6, 7, 8). This evidence concerns the gene NGF and neoplasm.